Abstract
Morphological and functional characteristics of erythrocytes, hemoglobin, and erythropoietin level in the venous blood were evaluated by laser interference microscopy, Raman spectroscopy with a short-focus extreme aperture lens monochromator, and by ELISA, respectively, in 30 patients with verified moderate COVID-19 at the time of hospitalization and 30 healthy volunteers. The patients whose course of COVID-19 has worsened to critical by day 5 had already had lower (p<0.001) indicators at the time of hospitalization such as the area and thickness of erythrocytes, the hemoglobin distribution and packing density, hemoglobin conformation index (I1355/I1550)/(I1375/I1580) reflecting its oxygen affinity, and blood erythropoietin content. Our findings suggest that these characteristics of erythrocytes, hemoglobin, and erythropoietin can serve as potential predictors of COVID-19 aggravation in hospitalized patients.
Key Words: COVID-19, worsening course markers, erythropoietin, erythrocytes, hemoglobin
Footnotes
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 173, No. 1, pp. 57-61, January, 2022
References
- 1.Kuznetsova EE, Gorokhova VG, Koryakina LB, Babushkina IV. Some aspects of the estimation of structuralfunctional changes in membrane of erythrocytes at the cardiovascular pathology. Acta Biomedica Scientifica. 2012;4-1:236–240. [Google Scholar]
- 2.Ushakova AA, Gromova NV, Revin VV, Mel’nikova NA, Revina ES, Martynova MI, Tyutyaev EV. the study of oxygen-binding properties of hemoglobin in erythrocytes in myocardial infarction. Arkhivarius. 2016;2(5):4-9. Russian. 3. Berzuini A, Bianco C, Migliorini AC, Maggioni M, Valenti L, Prati D. Red blood cell morphology in patients with COVID-19-related anaemia. Blood Transfus. 2021;19(1):34–36. doi: 10.2450/2020.0242-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, Dela Cruz CS, Dumont A, Halene S, Hwa J, Koff J, Menninger H, Neparidze N, Price C, Siner JM, Tormey C, Rinder HM, Chun HJ, Lee AI. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575–e582. doi: 10.1016/S2352-3026(20)30216-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Johnson CS, Cook CA, Furmanski P. In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNFalpha): reversal with exogenous erythropoietin (EPO) Exp. Hematol. 1990;18(2):109–113. [PubMed] [Google Scholar]
- 6.Kakavas S, Demestiha T, Vasileiou P, Xanthos T. Erythropoetin as a novel agent with pleiotropic effects against acute lung injury. Eur. J. Clin. Pharmacol. 2011;67(1):1–9. doi: 10.1007/s00228-010-0938-7. [DOI] [PubMed] [Google Scholar]
- 7.Libregts SF, Gutiérrez L, de Bruin AM, Wensveen FM, Papadopoulos P, van Ijcken W, Ozgür Z, Philipsen S, Nolte MA. Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis. Blood. 2011;118(9):2578–2588. doi: 10.1182/blood-2010-10-315218. [DOI] [PubMed] [Google Scholar]
- 8.Liu W, Li H. COVID-19: Attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. ChemRxiv. Cambridge: Cambridge Open Engage; 2021. 10.33774/chemrxiv-2021-dtpv3-v10
- 9.Lippi G, Mattiuzzi C. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol. Transfus. Cell Ther. 2020;42(2):116–117. doi: 10.1016/j.htct.2020.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Radaeva OA, Simbirtsev AS, Kostina YuA, Iskandiarova MS, Mashnina SV, Bessheynov DD, Negodnova EV, Kulyapkin VV. Changes in blood levels of IL1 family cytokines in patients with essential hypertension after having COVID-19. Bull. RSMU. 2021;(3). 10.24075/brsmu.2021.026
- 11.Rapp JL, Tremblay D, Alpert N, Lieberman-Cribbin W, Mascarenhas J, Taioli E, Ghaffari S. Red cell distribution width is associated with mortality in non-anemic patients with COVID-19. J. Med. Virol. 2021;93(7):4130–4132. doi: 10.1002/jmv.27011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Sahebnasagh A, Mojtahedzadeh M, Najmeddin F, Najafi A, Safdari M, Rezai Ghaleno H, Habtemariam S, Berindan-Neagoe I, Nabavi SM. A perspective on erythropoietin as a potential adjuvant therapy for acute lung injury/acute respiratory distress syndrome in patients with COVID-19. Arch. Med. Res. 2020;51(7):631–635. doi: 10.1016/j.arcmed.2020.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Thomas T, Stefanoni D, Dzieciatkowska M, Issaian A, Nemkov T, Hill RC, Francis RO, Hudson KE, Buehler PW, Zimring JC, Hod EA, Hansen KC, Spitalnik SL, D’Alessandro A. Evidence of structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients. J. Proteome Res. 2020;19(11):4455–4469. doi: 10.1021/acs.jproteome.0c00606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan. China. JAMA Intern. Med. 2020;180(7):934–943. doi: 10.1001/jamainternmed.2020.0994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Yağcı S, Serin E, Acicbe Ö, Zeren M.İ, Odabaşı MS. The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID-19. Int. J. Lab. Hematol. 2021;43(Suppl 1):142-151. 10.1111/ijlh.13479 [DOI] [PMC free article] [PubMed]